Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to establish a Cancer Immunoprevention Network (CIP-Net) to support a deeper understanding of basic mechanisms of immunoprevention, discover novel immunoprevention strategies, preclinical development and testing of interventions, and foster a community of cancer immunoprevention researchers. The UG3/UH3 research projects will enable de novo discovery of immune pathways, targets, immunoprevention mechanisms, or investigate the efficacy and potential side effects of new vaccines or immunomodulatory agents. Applicants responding to this NOFO must apply for both the UG3 and UH3 phases together in a single application. Achievement of the UG3 milestones will be necessary for the transition to the UH3 phase.
Application Due Date
LOI due 30 days before application due date